Jubilant Pharmova Ltd share price logo

Jubilant Pharmova Share Price

(JUBLPHARMA)

Check the latest share price of Jubilant Pharmova, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.

₹906.951%

as on 04:01PM, 02 May 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Jubilant Pharmova Performance

Get real-time share price information, day’s high and low, historical returns and market stats.

  • Day's Low

    Day's High

    ₹871.55
    Day's Price Range
    ₹909.7
  • 52 Week's Low

    52 Week's High

    ₹617.05
    52-Week Price Range
    ₹1,309.9
1 Month Return-6.55 %
3 Month Return-4.67 %
1 Year Return+ 32.16 %
Previous Close₹897.95
Open₹897.90
Volume1.58L
Upper Circuit₹1,077.50
Lower Circuit₹718.40
Market Cap₹14,447.71Cr

Jubilant Pharmova Fundamentals & Key Indicators

Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.

Market Cap

₹14,447.71 Cr

Return on Equity (ROE)

1.32

PE Ratio (TTM)

22.91

Return on capital employed (ROCE)

2.57

Beta (LTM)

0.95

P/B Ratio

3.81

Dividend Yield

0.88

PEG Ratio

0.62

EPS (TTM)

4.6

Sector

Pharmaceuticals

Technical Analysis

How to invest in Jubilant Pharmova

Investing in Jubilant Pharmova is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Jubilant Pharmova or JUBLPHARMA on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Jubilant Pharmova or start an SIP based on the market price on each investment date.

You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Jubilant Pharmova with just a few clicks!

Jubilant Pharmova Valuation

Track how the P/E of Jubilant Pharmova has moved over time to understand valuation trends.

Jubilant Pharmova in the last 5 years

  • Overview

  • Trends

Lowest (-195.50x)

December 29, 2023

Today (22.91x)

May 2, 2025

Industry (54.34x)

May 2, 2025

Highest (257.22x)

February 16, 2024

LowHigh

Today’s Price to Earnings Ratio: 22.91x

Analysts Recommendation on Jubilant Pharmova

Get updated buy, sell, and hold recommendations by analysts on Jubilant Pharmova.

based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

100% of analysts recommend a 'BUY' rating for Jubilant Pharmova. Average target price of ₹1310

Source: S&P Global Market Intelligence

Analysts Forecast on Jubilant Pharmova

Get share price movements and forecasts by analysts on Jubilant Pharmova.

Jubilant Pharmova price forecast by 2 analysts

Upside of44.44%

High

₹1385

Target

₹1310.00

Low

₹1235

Jubilant Pharmova target price ₹1310, a slight upside of 44.44% compared to current price of ₹906.95. According to 2 analysts rating.

Source: S&P Global Market Intelligence

Jubilant Pharmova Financials

Get the annual and quarterly financial summary of Jubilant Pharmova, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹1,665.20Cr (-)₹1,746.40Cr (↑4.88%)₹1,720.40Cr (↓1.49%)₹1,742.20Cr (↑1.27%)₹1,813.70Cr (↑4.10%)
Net Income₹66.40Cr (-)-₹61.80Cr (↓193.07%)₹481.80Cr (↓879.61%)₹102.50Cr (↓78.73%)₹100.70Cr (↓1.76%)
Net Profit Margin3.99% (-)-3.54% (↓188.72%)28.01% (↓891.24%)5.88% (↓79.01%)5.55% (↓5.61%)
Value in ₹ crore
Details2021202220232024
Total Assets₹1,844.59Cr (-)₹1,829.47Cr (↓0.82%)₹3,120.00Cr (↑70.54%)₹3,106.40Cr (↓0.44%)
Total Liabilities₹562.14Cr (-)₹547.65Cr (↓2.58%)₹705.50Cr (↑28.82%)₹731.90Cr (↑3.74%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹316.76Cr (-)₹608.38Cr (↑92.06%)-₹3.55Cr (↓100.58%)-₹65.10Cr (↑1,733.80%)₹143.20Cr (↓319.97%)

Jubilant Pharmova Index Inclusions

BSE Healthcare

₹41,995.12

-0.51 (-216.2%)

S&P BSE 250 SmallCap

₹6,157.39

-0.1 (-6.03%)

BSE Small-Cap

₹47,365.54

-0.07 (-34.77%)

Nifty MidSmallcap 400

₹18,151.50

-0.46 (-83.1%)

Nifty 500

₹22,006.00

-0.11 (-24.05%)

S&P BSE 400 MidSmallCap

₹11,047.95

-0.35 (-39.29%)

Nifty Smallcap 250

₹15,354.35

-0.03 (-5.1%)

BSE 500

₹34,623.50

-0.05 (-16.85%)

Jubilant Pharmova Earnings and Dividends

View detailed summary of the earnings and dividend history of Jubilant Pharmova.

  • Jubilant Pharmova Ltd Earnings Results

    Jubilant Pharmova Ltd’s net profit jumped 51.05% since last year same period to ₹100.90Cr in the Q3 2024-2025. On a quarterly growth basis, Jubilant Pharmova Ltd has generated -1.85% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Jubilant Pharmova Ltd Dividends May,2024

    In the quarter ending March 2024, Jubilant Pharmova Ltd has declared dividend of ₹5 - translating a dividend yield of 1.10%.

    Read More about Dividends

Jubilant Pharmova Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Jubilant Pharmova.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
50.68%
0.00
Foreign Institutions
17.22%
0.00
Mutual Funds
3.66%
0.00
Retail Investors
24.5%
0.00
Others
3.94%
0.00

Jubilant Pharmova vs Peers

Compare market cap, revenue, PE, and other key metrics of Jubilant Pharmova with its industry peers.

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
BUY₹14,447.71 Cr34.97%0.57₹72 Cr₹6,702 Cr
BUY₹28,910.94 Cr139.03%0.52₹300 Cr₹1,051 Cr
NA₹4,713.68 Cr1.53%0.79-₹388 Cr₹75 Cr
BUY₹13,813.06 Cr40.43%0.68₹218 Cr₹1,296 Cr
BUY₹25,289.89 Cr208.61%0.55₹258 Cr₹1,375 Cr

Jubilant Pharmova News & Key Events

Latest news and events at one place to help you take investing decisions in Jubilant Pharmova.

  • Jubilant Pharmova Chairman Cleared of Allegations - 21 Apr, 2025

    Jubilant Pharmova Limited announced that allegations against Chairman Shyam S. Bhartia were dismissed as baseless, with no material impact on the company's operations.

Insights on Jubilant Pharmova Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, JUBLPHARMA stock has moved up by 32.2%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 1.77K Cr → 1.83K Cr (in ₹), with an average increase of 3.1% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 16.96% to 17.22% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 3.64% to 3.66% in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 141.8% return, outperforming this stock by 36.8%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 50.68% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 54.5% return, outperforming this stock by 22.3%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 24.83% to 24.50% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 482.1 Cr → 100.9 Cr (in ₹), with an average decrease of 40.3% per quarter

About Jubilant Pharmova

Jubilant Pharmova Ltd is a well-established and leading pharmaceutical company, listed on the Stock Exchange of India. It provides world-class and innovative products and solutions to its customers in the Indian and global markets. It has a sound and strong presence in both the domestic and international markets. The company is focused towards delivering excellent quality healthcare solutions with the highest standards of safety and efficacy. It has implemented stringent quality management systems as well as advanced research and development activities, which enable them to produce quality products meeting all applicable regulatory requirements. With its strong commitment towards delivering excellence, the company takes pride in setting a benchmark in the pharmaceutical industry.

Revenue: ₹1,813.70Cr as on December 2024 (Q4 24)
Net Profit: ₹100.70Cr as on December 2024 (Q4 24)
Listing date: 09 Nov, 1994
Chairperson Name: Shyam S Bhartia
OrganisationJubilant Pharmova Ltd
HeadquartersNoida
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Indian Mutual Funds that own Jubilant Pharmova

Check out the Mutual Funds with significant holdings in Jubilant Pharmova.

FAQs

What is Jubilant Pharmova Ltd price today?

Jubilant Pharmova Ltd share price today stands at ₹906.95, Open: ₹897.9, Previous Close: ₹897.95, High: ₹909.7, Low: ₹871.55, 52 Week High: ₹1309.9, 52 Week Low: ₹617.05.

How to Buy Jubilant Pharmova Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Jubilant Pharmova Ltd shares

What are today's traded volumes of Jubilant Pharmova Ltd?

Today's traded volume of Jubilant Pharmova Ltd(JUBLPHARMA) is 1.58L.

What is today's market capitalisation of Jubilant Pharmova Ltd?

Today's market capitalisation of Jubilant Pharmova Ltd(JUBLPHARMA) is ₹14,447.71 Cr.

What is the 52 Week High and Low Range of Jubilant Pharmova Ltd?

Jubilant Pharmova Ltd (JUBLPHARMA)
Price
52 Week High
₹1309.9
52 Week Low
₹617.05

How much percentage Jubilant Pharmova Ltd is down from its 52 Week High?

Jubilant Pharmova Ltd (JUBLPHARMA) share price is ₹906.95. It is down -30.76% from its 52 Week High price of ₹1309.9

How much percentage Jubilant Pharmova Ltd is up from its 52 Week low?

Jubilant Pharmova Ltd (JUBLPHARMA) share price is ₹906.95. It is up 46.98% from its 52 Week Low price of ₹617.05